Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Heart, Lung and Vessels|December 24, 2013
Levosimendan: current data, clinical use and future developmentM S Nieminen, S Fruhwald, L M A Heunks, et al.The Journal of Biological Chemistry|September 20, 1997
Cellular UDP-glucose deficiency caused by a single point mutation in the UDP-glucose pyrophosphorylase geneM Flores-Díaz, A Alape-Girón, B Persson, et al.The Journal of Cell Biology|October 1, 1986
Biochemical and immunohistochemical evidence that in cartilage an alkaline phosphatase is a Ca2+-binding glycoproteinB de Bernard, P Bianco, E Bonucci, et al.Journal of Magnetic Resonance Imaging : JMRI|May 1, 1995
Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosisR Longo, P Pollesello, C Ricci, et al.Experimental Cell Research|January 1, 1994
Energy metabolism, replicative ability, intracellular calcium concentration, and ionic channels of horse articular chondrocytesF Vittur, M Grandolfo, E Fragonas, et al.The Journal of Biological Chemistry|December 23, 2000
Binding of levosimendan, a calcium sensitizer, to cardiac troponin CT Sorsa, S Heikkinen, M B Abbott, et al.Journal of Hepatology|July 1, 1997
Noninvasive in vivo quantitative assessment of fat content in human liverC Ricci, R Longo, E Gioulis, et al.International Journal of Cardiology|August 5, 2015
Pharmaco-economics of levosimendan in cardiology: a European perspectiveM S Nieminen, M Buerke, J Parissis, et al.British Journal of Pharmacology|May 8, 2013
ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heartN Jost, N Nagy, C Corici, et al.Journal of Anesthesia, Analgesia and Critical Care|June 29, 2023
Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safetyM Girardis, D Bettex, M Bojan, et al.Pageof 7